Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | Modular Medical, Inc.: Modular Medical Receives IRB Approval for Pivot Insulin Delivery System Feasibility Study | 118 | ACCESS Newswire | -Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or... ► Artikel lesen | |
Do | Modular Medical, Inc.: Modular Medical Announces Completion of Clinical Study of MODD1 Pump | 819 | ACCESS Newswire | - Use of MODD1 on clinicians with Type 1 diabetes SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery... ► Artikel lesen | |
27.08. | Modular Medical gets insulin pump cartridge production ready for commercial activity | 3 | MassDevice | ||
26.08. | Modular Medical, Inc.: Modular Medical Announces Completion of MODD1 Cartridge Production and Commencement of Pivot Conversion | 539 | ACCESS Newswire | -More than 6,000 MODD1 cartridges produced- Conversion to Pivot-ready manufacturing in preparation for product launch in 1Q26 SAN DIEGO, CA / ACCESS Newswire / August 26, 2025 / Modular Medical, Inc.... ► Artikel lesen | |
11.08. | Modular Medical unveils next-gen insulin patch pump, expects FDA submission this fall | 1 | MassDevice | ||
08.08. | Modular Medical, Inc.: Modular Medical Announces Next-Generation Pivot Insulin Pump at ADCES and Introduction of Level Ex Gamified Training Collaboration | 447 | ACCESS Newswire | -Debuting a "coming soon" campaign for tubeless Pivot patch pump- Expects special 510(k) filing for Pivot product in October- Will introduce first level of its gamified training application developed... ► Artikel lesen | |
MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
06.08. | Modular Medical, Inc.: Modular Medical Announces First Human Use of MODD1 Pump Delivering Insulin | 316 | ACCESS Newswire | - Use of MODD1 on clinician with Type 1 diabetes- Modular Medical intends to deploy the MODD1 on a larger number of clinicians in mid August SAN DIEGO, CA / ACCESS Newswire / August 6, 2025 / Modular... ► Artikel lesen | |
04.08. | Modular Medical, Inc.: Modular Medical Announces MODD1 Cartridge Line Validated for Human-Use Production | 139 | ACCESS Newswire | -Line has been in production at risk since early July- Production to continue until late August when conversion to Pivot manufacturing will begin SAN DIEGO, CA / ACCESS Newswire / August 4, 2025 / Modular... ► Artikel lesen | |
02.07. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
20.06. | Modular Medical, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
16.06. | Modular Medical, Inc.: Modular Medical to Present Data from Study Examining Pump Delivery of a GLP-1R Agonist at the ADA 85th Scientific Sessions | 229 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump... ► Artikel lesen | |
28.05. | Modular Medical appoints Jeff Goldberg to board | 1 | Investing.com | ||
28.05. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
28.05. | Modular Medical, Inc.: Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors | 529 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / May 28, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump... ► Artikel lesen | |
27.05. | Modular Medical, Inc.: Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy" Featuring Modular Medical CEO - Wednesday, May 28, 2025 | 408 | ACCESS Newswire | Meet with Modular Medical CEO Jeb BesserThere are 1.9 million individuals with Type 1 Diabetes in the US. 100% of patient population require daily insulin injection. Only 1 out of 3 currently use an... ► Artikel lesen | |
22.05. | Modular Medical, Inc.: Modular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025 | 256 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / May 22, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump... ► Artikel lesen | |
26.03. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
20.03. | Modular Medical secures $12 million in private placement | 4 | Investing.com | ||
20.03. | Modular Medical, Inc.: Modular Medical Announces $12 Million Private Placement | 382 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / March 20, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump... ► Artikel lesen | |
30.01. | Modular Medical, Inc.: Modular Medical Announces BSI Group as Trusted Body for CE Mark Clearance | 264 | ACCESS Newswire | - Engaged BSI Group to start the process of obtaining regulatory clearance of the MODD1, next-generation insulin pump for the European market- Targeting Q1 2026 for expected clearance of the MODD1 in... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 46,860 | +0,69 % | +40 Prozent seit Jahresbeginn: Fresenius kehrt mit Milliarden-Anleihe zurück - Analysten empfehlen zum Kauf! | © Foto: Arne Dedert/dpaFresenius stärkt mit einer Milliarden-Anleihe seine Bilanz und Analysten sehen trotz Rallye weiteres Kurspotenzial für die Aktie.Der Gesundheitskonzern Fresenius ist mit einer... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 42,060 | -1,04 % | FMC, Hugo Boss, K+S, Redcare Pharmacy, Renk, ThyssenKrupp - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,810 | +0,40 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers nach einem Kreise-Bericht über einen möglichen Verkauf des Diagnostikbereichs auf "Buy" mit einem... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 16,320 | +1,81 % | Alignment Healthcare, Inc. - 8-K, Current Report | ||
GERRESHEIMER | 43,100 | +2,04 % | Evotec, Gerresheimer, Hugo Boss, Lufthansa, Northern Data, SMA Solar - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
KINDLY MD | 1,240 | 0,00 % | KindlyMD, Inc: KindlyMD Approved for Options Trading on Nasdaq | SALT LAKE CITY, UT / ACCESS Newswire / September 10, 2025 / KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or "the Company"), a provider of integrated healthcare services and a Bitcoin treasury vehicle via... ► Artikel lesen | |
NANOVIBRONIX | 10,700 | 0,00 % | NanoVibronix files to sell 1.35M shares of common stock for holders | ||
BRIGHTSPRING HEALTH SERVICES | 27,180 | +2,76 % | BrightSpring Health: UBS bestätigt Kaufempfehlung angesichts starker Wachstumsaussichten | ||
UNITEDHEALTH | 296,00 | +0,07 % | Neues Futter für Bullen: UnitedHealth überrascht mit Gewinnprognose für 2025 - Aktie steigt! | © Foto: SOPA Images - Sipa USAUnitedHealth bekräftigt trotz steigender Kosten seinen Jahresausblick, die Aktie reagiert mit einem Kurssprung von 1,5 Prozent.Die Aktie von UnitedHealth Group legte am... ► Artikel lesen | |
CARL ZEISS MEDITEC | 42,900 | +0,37 % | Carl Zeiss Meditec, HelloFresh, Hensoldt, Lanxess, SMA Solar, Suss MicroTec - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
ECKERT & ZIEGLER | 17,270 | +0,58 % | EQS-News: Eckert & Ziegler SE: Berenberg startet Coverage mit "Kauf"-Empfehlung und Kursziel von 24 € - Kurspotenzial 47% | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Research Update
Eckert & Ziegler: Berenberg startet Coverage mit "Kauf"-Empfehlung und Kursziel von 24 € - Kurspotenzial 47%
09.09.2025... ► Artikel lesen | |
BETA BIONICS | 25,310 | -4,17 % | Beta Bionics, Inc.: Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
OPTIMIZERX | 17,330 | 0,00 % | OptimizeRx Corporation: OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising |
Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar's Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept.... ► Artikel lesen | |
HIMS & HERS HEALTH | 45,950 | +0,15 % | US-Börsenliebling Hims & Hers kauft Zava - Abnehmspritzen und Potenzpillen erobern Deutschland | ||
PRIVIA HEALTH GROUP | 22,340 | -1,93 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen |